In regulated industries like life sciences, quality and manufacturing have traditionally been built for assurance, not agility. The mission was clear: Ensure compliance, maintain control and reduce ...

Real-time batch monitoring powered by machine learning is helping manufacturers detect deviations early to reduce failures, improve consistency and cut costs. By simulating cell and gene therapy ...

Olivia Gannon, Associate Director of Global MES and Digital Execution Systems, Life Sciences Manufacturing, Cognizant, explores how a digitalization strategy harnessing the latest innovations in MES ...

In the high-stakes world of Formula 1 racing, speed and precision are the keys to victory. Every millisecond and every detail counts. Interestingly, the same principles that drive success on the ...

It’s no longer a question if these companies will grow; it’s about how and where they choose to grow to offer flexibility, ...

New research in orbital semiconductors, space-based metal 3D printing, and in-space recycling pushes production beyond and reveals lessons for advanced manufacturing on ...

Forma Life Sciences, which inherited BioDuro’s California production operations earlier this year, has officially ...

Process validation is crucial for ensuring the quality of final products and the safety of these processes for manufacturing personnel and consumers in the pharmaceutical, medical device, and ...

What is Real-Time Release Testing? Real-Time Release Testing (RTRT) is an advanced approach to biopharmaceutical manufacturing quality control that improves upon current systems. RTRT is defined as ...

Forma Life Sciences has launched as an independent, operator-owned contract development and manufacturing organization (CDMO) in the U.S. The new CDMO is focused on oral solid dosage formulation ...

Two life sciences manufacturing hubs are coming to fruition in the U.S., adding to the wave of projects sparked by President Donald Trump's domestic manufacturing push. Biotech company Greentech is ...

Illinois Gov. JB Pritzker on Monday announced a $1.5 billion investment from biotherapeutics company CSL for a new plasma therapy manufacturing plant in Kanakee.